%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Miriam Rosás-Umbert, Beatriz Mothe, Marc Noguera-Julian, Rocío Bellido, Maria C. Puertas, Jorge Carrillo, C. Rodriguez, Núria Perez-Alvarez, Patricia Cobarsí, Carmen E. Gomez, Mariano Esteban, Jose Luis Jímenez, Felipe García, Julià Blanco, Javier Martinez-Picado, Roger Paredes, Christian Brander
Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref004)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref005)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref006)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref007)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref008)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref009)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref010)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref011)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref012)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref013)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref014)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref015)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref016)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref014)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184929.ref014)>>
endobj
33 0 obj
<>/Border[0 0 0]/A 34 0 R>>
endobj
34 0 obj
<>
endobj
14 0 obj
[35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R]
endobj
35 0 obj
<>stream
q
0.83 0.64 0.02 0 k
248.6551 649.0205 m
253.4173 649.0205 l
h
f*
260.2205 649.0205 m
264.9827 649.0205 l
h
f*
271.7858 649.0205 m
276.548 649.0205 l
h
f*
283.3512 649.0205 m
288.0567 649.0205 l
h
f*
435.1181 532.0063 m
439.8803 532.0063 l
h
f*
446.6835 532.0063 m
451.4457 532.0063 l
h
f*
458.2488 532.0063 m
462.9543 532.0063 l
h
f*
469.7575 532.0063 m
474.5197 532.0063 l
h
f*
522.3118 493.0016 m
527.074 493.0016 l
h
f*
533.8772 493.0016 m
543.4016 493.0016 l
h
f*
550.2047 493.0016 m
559.6724 493.0016 l
h
f*
471.9685 480.0189 m
481.4929 480.0189 l
h
f*
226.4882 402.0094 m
236.0126 402.0094 l
h
f*
334.2047 311.0173 m
343.7291 311.0173 l
h
f*
350.5323 311.0173 m
360.0567 311.0173 l
h
f*
366.8598 311.0173 m
376.3276 311.0173 l
h
f*
348.1512 133.9087 m
357.4488 133.9087 l
h
f*
322.0157 107.9433 m
331.3701 107.9433 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Effective)Tj
3.6566 0 Td
(treatments)Tj
4.4957 0 Td
(for)Tj
1.3833 0 Td
(human)Tj
3.0784 0 Td
(immunodeficiency)Tj
7.7556 0 Td
(virus)Tj
2.2053 0 Td
(\(HIV\))Tj
2.7043 0 Td
(infection)Tj
3.787 0 Td
(exist)Tj
2.0353 0 Td
(and)Tj
1.7291 0 Td
(combina-)Tj
-32.8306 -1.3039 Td
(tion)Tj
1.8425 0 Td
(antiretroviral)Tj
5.5105 0 Td
(therapy)Tj
3.2485 0 Td
(\(cART\))Tj
3.2371 0 Td
(has)Tj
1.542 0 Td
(resulted)Tj
3.4016 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.6519 0 Td
(dramatic)Tj
3.7928 0 Td
(decrease)Tj
3.6113 0 Td
(in)Tj
1.0375 0 Td
(morbidity)Tj
4.2349 0 Td
(and)Tj
1.7348 0 Td
(mor-)Tj
-34.8829 -1.2982 Td
(tality.)Tj
2.4434 0 Td
(However,)Tj
4.0762 0 Td
(cART)Tj
2.5625 0 Td
(poses)Tj
2.3868 0 Td
(enormous)Tj
4.2859 0 Td
(challenges)Tj
4.32 0 Td
(on)Tj
1.2756 0 Td
(global)Tj
2.6248 0 Td
(implementation)Tj
6.6387 0 Td
(and)Tj
1.7292 0 Td
(is)Tj
0.8503 0 Td
(not)Tj
1.5761 0 Td
(free)Tj
1.7234 0 Td
(of)Tj
-36.4929 -1.2983 Td
(side)Tj
1.7971 0 Td
(effects)Tj
2.7269 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
5.0683 0 Td
(Since)Tj
2.3584 0 Td
(HIV)Tj
2.024 0 Td
(forms)Tj
2.5625 0 Td
(latent)Tj
2.4718 0 Td
(viral)Tj
1.9955 0 Td
(reservoirs)Tj
4.1273 0 Td
(from)Tj
2.2053 0 Td
(which)Tj
2.6532 0 Td
(the)Tj
1.4683 0 Td
(virus)Tj
2.1997 0 Td
(reacti-)Tj
-33.6583 -1.3039 Td
(vates)Tj
2.1883 0 Td
(and)Tj
1.7348 0 Td
(replicates)Tj
3.9855 0 Td
(when)Tj
2.4037 0 Td
(treatment)Tj
4.1329 0 Td
(is)Tj
0.8504 0 Td
(interrupted,)Tj
5.0173 0 Td
(cART)Tj
2.5625 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6576 0 Td
(non-curative)Tj
5.3745 0 Td
(life-long)Tj
3.5603 0 Td
(treatment.)Tj
-33.3125 -1.2983 Td
(Therapeutic)Tj
5.0456 0 Td
(vaccination)Tj
4.8245 0 Td
(in)Tj
1.0375 0 Td
(infected)Tj
3.4186 0 Td
(individuals)Tj
4.6487 0 Td
(aims)Tj
2.1033 0 Td
(to)Tj
1.0262 0 Td
(boost)Tj
2.3981 0 Td
(adaptive)Tj
3.5773 0 Td
(immunity)Tj
4.2236 0 Td
(against)Tj
3.0274 0 Td
(HIV)Tj
-35.3308 -1.2982 Td
(and)Tj
1.7291 0 Td
(help)Tj
1.9332 0 Td
(to)Tj
1.0261 0 Td
(maintain)Tj
3.8381 0 Td
(viral)Tj
1.9956 0 Td
(replication)Tj
4.5241 0 Td
(at)Tj
0.9524 0 Td
(undetectable)Tj
5.3007 0 Td
(or)Tj
1.0942 0 Td
(low-levels)Tj
4.1669 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(absence)Tj
3.3392 0 Td
(of)Tj
1.0148 0 Td
(cART.)Tj
-33.4202 -1.304 Td
(The)Tj
1.7801 0 Td
(safe)Tj
1.7291 0 Td
(development)Tj
5.4085 0 Td
(of)Tj
1.0148 0 Td
(such)Tj
2.0579 0 Td
(strategies)Tj
3.9232 0 Td
(is)Tj
0.8503 0 Td
(complicated)Tj
5.108 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(lack)Tj
1.8199 0 Td
(of)Tj
1.0148 0 Td
(well-defined)Tj
5.176 0 Td
(parameters)Tj
-32.5358 -1.2982 Td
(of)Tj
1.0147 0 Td
(HIV)Tj
2.0183 0 Td
(immune)Tj
3.6283 0 Td
(control)Tj
3.1238 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(uncertainties)Tj
5.4142 0 Td
(regarding)Tj
4.0932 0 Td
(most)Tj
2.2053 0 Td
(suitable)Tj
3.2882 0 Td
(endpoints)Tj
4.2179 0 Td
(in)Tj
1.0318 0 Td
(clinical)Tj
-33.2331 -1.2983 Td
(vaccine)Tj
3.1917 0 Td
(trials.)Tj
2.4265 0 Td
(While)Tj
2.6475 0 Td
(results)Tj
2.812 0 Td
(from)Tj
2.2053 0 Td
(cross-sectional)Tj
6.1001 0 Td
(cohorts)Tj
3.2202 0 Td
(of)Tj
1.0148 0 Td
(natural)Tj
3.0784 0 Td
(HIV)Tj
2.0239 0 Td
(infection)Tj
3.7871 0 Td
(point)Tj
2.3584 0 Td
(to)Tj
1.0261 0 Td
(var-)Tj
-35.892 -1.2983 Td
(ious)Tj
1.8821 0 Td
(immune)Tj
3.6284 0 Td
(markers)Tj
3.4922 0 Td
(that)Tj
1.7802 0 Td
(are)Tj
1.4513 0 Td
(associated)Tj
4.2519 0 Td
(with)Tj
2.0013 0 Td
(viral)Tj
1.9899 0 Td
(load,)Tj
2.16 0 Td
(no)Tj
1.2756 0 Td
(robust)Tj
2.7949 0 Td
(immune)Tj
3.6283 0 Td
(parameters)Tj
4.6715 0 Td
(have)Tj
-35.0076 -1.3039 Td
(been)Tj
2.1203 0 Td
(identified)Tj
4.0591 0 Td
(that)Tj
1.7802 0 Td
(could)Tj
2.4491 0 Td
(serve)Tj
2.2564 0 Td
(as)Tj
1.0148 0 Td
(reliable)Tj
3.1407 0 Td
(predictors)Tj
4.286 0 Td
(of)Tj
1.0148 0 Td
(viral)Tj
1.9956 0 Td
(control)Tj
3.1181 0 Td
(in)Tj
1.0374 0 Td
(patients)Tj
3.3676 0 Td
(receiving)Tj
3.8664 0 Td
(ther-)Tj
-35.5065 -1.2982 Td
(apeutic)Tj
3.1124 0 Td
(vaccines)Tj
3.5546 0 Td
(and)Tj
1.7291 0 Td
(interrupting)Tj
5.125 0 Td
(antiretroviral)Tj
5.5105 0 Td
(treatment)Tj
4.1386 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
-21.974 -1.2983 Td
(Past)Tj
1.8765 0 Td
(therapeutic)Tj
4.7281 0 Td
(vaccine)Tj
3.1975 0 Td
(trials)Tj
2.1997 0 Td
(have)Tj
2.0579 0 Td
(oftentimes)Tj
4.4561 0 Td
(included)Tj
3.7133 0 Td
(structured)Tj
4.3483 0 Td
(treatment)Tj
4.1386 0 Td
(interruptions)Tj
-31.9122 -1.3039 Td
(\(STI\))Tj
2.3243 0 Td
(to)Tj
1.0262 0 Td
(assess)Tj
2.5228 0 Td
(the)Tj
1.4683 0 Td
(efficacy)Tj
3.2202 0 Td
(of)Tj
1.0148 0 Td
(tested)Tj
2.5568 0 Td
(vaccines)Tj
3.5546 0 Td
(and)Tj
1.7292 0 Td
(used)Tj
2.0579 0 Td
(control)Tj
3.1238 0 Td
(of)Tj
1.0147 0 Td
(viral)Tj
1.9956 0 Td
(rebound)Tj
3.6283 0 Td
(and/or)Tj
2.9424 0 Td
(preven-)Tj
-34.1799 -1.2983 Td
(tion)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(CD4)Tj
2.0919 0 Td
(T-cell)Tj
2.5228 0 Td
(decay)Tj
2.4832 0 Td
(upon)Tj
2.3187 0 Td
(treatment)Tj
4.1385 0 Td
(cessation)Tj
3.8438 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(primary)Tj
3.4526 0 Td
(trial)Tj
1.8368 0 Td
(endpoint)Tj
3.8608 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
-31.8895 -1.2982 Td
(However,)Tj
4.0761 0 Td
(STI)Tj
1.6441 0 Td
(is)Tj
0.8504 0 Td
(not)Tj
1.5761 0 Td
(free)Tj
1.7234 0 Td
(of)Tj
1.0148 0 Td
(risk)Tj
1.7178 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(health)Tj
2.6759 0 Td
(of)Tj
1.0148 0 Td
(infected)Tj
3.4185 0 Td
(individuals)Tj
4.6488 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
2.0806 0 Td
(Therefore,)Tj
4.3937 0 Td
(it)Tj
0.7824 0 Td
(is)Tj
0.8503 0 Td
(gener-)Tj
-34.9622 -1.304 Td
(ally)Tj
1.5987 0 Td
(only)Tj
1.9786 0 Td
(considered)Tj
4.5977 0 Td
(in)Tj
1.0375 0 Td
(well-controlled)Tj
6.2702 0 Td
(clinical)Tj
3.0784 0 Td
(trials)Tj
2.194 0 Td
(that)Tj
1.7801 0 Td
(exclude)Tj
3.2599 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(low)Tj
1.6554 0 Td
(CD4)Tj
-32.8136 -1.2982 Td
(counts,)Tj
3.1124 0 Td
(limit)Tj
2.1146 0 Td
(the)Tj
1.474 0 Td
(duration)Tj
3.6964 0 Td
(of)Tj
1.0148 0 Td
(treatment)Tj
4.1385 0 Td
(cessation)Tj
3.8438 0 Td
(and)Tj
1.7291 0 Td
(use)Tj
1.5307 0 Td
(very)Tj
1.9275 0 Td
(stringent)Tj
3.7984 0 Td
(immune)Tj
3.6284 0 Td
(and)Tj
1.7291 0 Td
(virologi-)Tj
-33.7377 -1.2983 Td
(cal)Tj
1.3209 0 Td
(criteria)Tj
3.0784 0 Td
(for)Tj
1.3833 0 Td
(treatment)Tj
4.1385 0 Td
(resumption)Tj
4.8586 0 Td
(after)Tj
2.0353 0 Td
(vaccine)Tj
3.1974 0 Td
(failure.)Tj
3.0047 0 Td
(A)Tj
0.9014 0 Td
(possibly)Tj
3.4413 0 Td
(less)Tj
1.61 0 Td
(harmful)Tj
3.4356 0 Td
(approach)Tj
3.9515 0 Td
(to)Tj
-36.3569 -1.2983 Td
(STI)Tj
1.644 0 Td
(may)Tj
1.9276 0 Td
(be)Tj
1.1508 0 Td
(the)Tj
1.474 0 Td
(so-called)Tj
3.7361 0 Td
(monitored)Tj
4.8812 0 Td
(anti-retroviral)Tj
5.8677 0 Td
(pause)Tj
2.8743 0 Td
(\(MAP\))Tj
3.0331 0 Td
(where)Tj
2.6532 0 Td
(treatment)Tj
4.1329 0 Td
(is)Tj
0.8503 0 Td
(re-)Tj
-34.2252 -1.3039 Td
(started)Tj
2.931 0 Td
(at)Tj
0.9524 0 Td
(a)Tj
0.6576 0 Td
(pre-set)Tj
2.965 0 Td
(\(low\))Tj
2.3358 0 Td
(level)Tj
2.0126 0 Td
(of)Tj
1.0148 0 Td
(viral)Tj
1.9955 0 Td
(replication)Tj
4.5241 0 Td
(instead)Tj
3.0784 0 Td
(of)Tj
1.0148 0 Td
(after)Tj
2.0353 0 Td
(a)Tj
0.6576 0 Td
(pre-defined)Tj
4.8869 0 Td
(period)Tj
2.8346 0 Td
(off)Tj
1.304 0 Td
(treat-)Tj
-35.2004 -1.2982 Td
(ment)Tj
2.3073 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.0807 0 Td
(In)Tj
1.1055 0 Td
(either)Tj
2.5341 0 Td
(way)Tj
1.7915 0 Td
(though,)Tj
3.2995 0 Td
(better)Tj
2.5398 0 Td
(predictors)Tj
4.2917 0 Td
(of)Tj
1.0148 0 Td
(viral)Tj
1.9899 0 Td
(rebound)Tj
3.634 0 Td
(during)Tj
2.9253 0 Td
(MAP/STI)Tj
4.1159 0 Td
(are)Tj
-33.63 -1.2983 Td
(urgently)Tj
3.5546 0 Td
(needed)Tj
3.0954 0 Td
(to)Tj
1.0261 0 Td
(reduce)Tj
2.914 0 Td
(the)Tj
1.4684 0 Td
(risk)Tj
1.7177 0 Td
(of)Tj
1.0148 0 Td
(conducting)Tj
4.7565 0 Td
(unyielding)Tj
4.4958 0 Td
(STI)Tj
1.6497 0 Td
(and)Tj
1.7291 0 Td
(to)Tj
1.0262 0 Td
(adjust)Tj
2.6248 0 Td
(trial)Tj
1.8369 0 Td
(design)Tj
2.8119 0 Td
(to)Tj
-35.7219 -1.3039 Td
(maximize)Tj
4.1272 0 Td
(vaccination)Tj
4.8245 0 Td
(outcome.)Tj
-7.7555 -1.2983 Td
(Here,)Tj
2.4321 0 Td
(we)Tj
1.3266 0 Td
(tested)Tj
2.5568 0 Td
(such)Tj
2.058 0 Td
(potential)Tj
3.7587 0 Td
(predictors)Tj
4.2916 0 Td
(of)Tj
1.0148 0 Td
(vaccine)Tj
3.1918 0 Td
(outcome)Tj
3.7304 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(recently)Tj
3.4072 0 Td
(completed)Tj
4.405 0 Td
(thera-)Tj
-35.0586 -1.2983 Td
(peutic)Tj
2.6758 0 Td
(vaccine)Tj
3.1975 0 Td
(trial,)Tj
2.0579 0 Td
(referred)Tj
3.4243 0 Td
(to)Tj
1.0261 0 Td
(as)Tj
1.0148 0 Td
(RISVAC03.)Tj
4.8756 0 Td
(This)Tj
1.9842 0 Td
(trial)Tj
1.8368 0 Td
(was)Tj
1.7008 0 Td
(a)Tj
0.652 0 Td
(double-blinded)Tj
6.3552 0 Td
(phase)Tj
2.4888 0 Td
(I)Tj
0.5556 0 Td
(clinical)Tj
-33.8454 -1.3039 Td
(trial)Tj
1.8368 0 Td
(that)Tj
1.7745 0 Td
(assessed)Tj
3.4752 0 Td
(the)Tj
1.4684 0 Td
(safety)Tj
2.4831 0 Td
(and)Tj
1.7291 0 Td
(immunogenicity)Tj
6.8541 0 Td
(of)Tj
1.0148 0 Td
(an)Tj
1.2076 0 Td
(MVA-B)Tj
3.4186 0 Td
(candidate)Tj
4.1045 0 Td
(vaccine)Tj
3.1975 0 Td
(given)Tj
2.3754 0 Td
(alone)Tj
-34.9396 -1.2982 Td
(or)Tj
1.0941 0 Td
(in)Tj
1.0375 0 Td
(combination)Tj
5.3461 0 Td
(with)Tj
2.0012 0 Td
(disulfiram)Tj
4.3257 0 Td
(in)Tj
1.0375 0 Td
(chronically)Tj
4.6714 0 Td
(infected,)Tj
3.6454 0 Td
(cART)Tj
2.5625 0 Td
(treated)Tj
2.9933 0 Td
(individuals)Tj
4.6488 0 Td
(who)Tj
-33.3635 -1.2983 Td
(underwent)Tj
4.575 0 Td
(STI)Tj
1.6441 0 Td
(post-vaccination)Tj
6.8598 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(][)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
5.3405 0 Td
(In)Tj
1.1055 0 Td
(the)Tj
1.474 0 Td
(present)Tj
3.1634 0 Td
(work,)Tj
2.5002 0 Td
(we)Tj
1.3322 0 Td
(sought)Tj
2.9027 0 Td
(to)Tj
1.0261 0 Td
(integrate)Tj
3.7531 0 Td
(host)Tj
-35.6766 -1.3039 Td
(and)Tj
1.7291 0 Td
(vaccine-induced)Tj
6.7917 0 Td
(virological)Tj
4.4107 0 Td
(and)Tj
1.7291 0 Td
(immune)Tj
3.6227 0 Td
(parameters)Tj
4.6771 0 Td
(in)Tj
1.0375 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0204 0 Td
(study)Tj
2.3925 0 Td
(possible)Tj
3.4072 0 Td
(vaccine-)Tj
-33.2388 -1.2983 Td
(exerted)Tj
3.1521 0 Td
(effects)Tj
2.7269 0 Td
(on)Tj
1.2756 0 Td
(rebounding)Tj
4.9095 0 Td
(virus,)Tj
2.4321 0 Td
(and)Tj
1.7292 0 Td
(to)Tj
1.0261 0 Td
(define)Tj
2.6986 0 Td
(correlates)Tj
4.0762 0 Td
(of)Tj
1.0148 0 Td
(viral)Tj
1.9955 0 Td
(rebound)Tj
3.634 0 Td
(dynamics)Tj
4.0535 0 Td
(after)Tj
-34.7241 -1.2982 Td
(STI.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 247.0677 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Material)Tj
3.959 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 230.0598 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(study)Tj
2.3924 0 Td
(was)Tj
1.6951 0 Td
(approved)Tj
3.9742 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(Ethical)Tj
2.9877 0 Td
(Comitee)Tj
3.617 0 Td
(of)Tj
1.0148 0 Td
(Hospital)Tj
3.6226 0 Td
(Clinic)Tj
2.6362 0 Td
(de)Tj
1.1679 0 Td
(Barcelona)Tj
4.1896 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(trial)Tj
-34.9282 -1.3039 Td
(was)Tj
1.6951 0 Td
(registered)Tj
4.1555 0 Td
(at)Tj
0.9525 0 Td
(Clinicaltrials.gov)Tj
6.9448 0 Td
(number:)Tj
3.6453 0 Td
(NCT01571466.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 190.9984 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Patients)Tj
3.7937 0 Td
(and)Tj
1.8661 0 Td
(samples)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 173.9905 cm
BT
/F8 1 Tf
1 TL
-0.013 Tc
0 0 Td
(The)Tj
1.7517 0 Td
(RISVAC03)Tj
4.5808 0 Td
(study)Tj
2.3471 0 Td
(was)Tj
1.6724 0 Td
(a)Tj
0.6406 0 Td
(phase)Tj
2.4378 0 Td
(I)Tj
0.5556 0 Td
(double)Tj
2.9027 0 Td
(blinded,)Tj
3.4242 0 Td
(placebo-controlled)Tj
7.5628 0 Td
(therapeutic)Tj
4.6318 0 Td
(vaccine)Tj
3.1351 0 Td
(trial)Tj
-35.6426 -1.2982 Td
(using)Tj
2.3414 0 Td
(an)Tj
1.1848 0 Td
(MVA)Tj
2.4662 0 Td
(vector)Tj
2.6418 0 Td
(expressing)Tj
4.337 0 Td
(HIV-1)Tj
2.8006 0 Td
(antigens)Tj
3.4979 0 Td
(from)Tj
2.1657 0 Td
(clade)Tj
2.2337 0 Td
(B)Tj
0.788 0 Td
(\(Bx08)Tj
2.5115 0 Td
(gp120)Tj
2.5852 0 Td
(and)Tj
1.7064 0 Td
(IIIB)Tj
1.7802 0 Td
(gag/pol/)Tj
-33.0404 -1.2983 Td
(nef\))Tj
1.7801 0 Td
(with)Tj
1.9616 0 Td
(or)Tj
1.0828 0 Td
(without)Tj
3.2655 0 Td
(a)Tj
0.6463 0 Td
(drug)Tj
2.0749 0 Td
(to)Tj
1.0091 0 Td
(reactivate)Tj
3.9572 0 Td
(latent)Tj
2.4151 0 Td
(HIV)Tj
1.9956 0 Td
(\(disulfiram\))Tj
4.9039 0 Td
(in)Tj
1.0148 0 Td
(successfully)Tj
4.7565 0 Td
(cART-treated,)Tj
-30.8634 -1.3039 Td
(chronically)Tj
4.5694 0 Td
(HIV-positive)Tj
5.3631 0 Td
(individuals)Tj
4.5467 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.0353 0 Td
(Of)Tj
1.2359 0 Td
(the)Tj
1.44 0 Td
(30)Tj
1.1565 0 Td
(volunteers)Tj
4.2916 0 Td
(that)Tj
1.7405 0 Td
(participated)Tj
4.8926 0 Td
(in)Tj
1.0148 0 Td
(the)Tj
1.4456 0 Td
(study,)Tj
2.5625 0 Td
(28)Tj
-36.2945 -1.2983 Td
(underwent)Tj
4.49 0 Td
(an)Tj
1.1849 0 Td
(STI)Tj
1.6214 0 Td
(after)Tj
1.9899 0 Td
(completing)Tj
4.6488 0 Td
(full)Tj
1.491 0 Td
(vaccination)Tj
4.7282 0 Td
(regimens)Tj
3.8267 0 Td
(consisting)Tj
4.1782 0 Td
(of)Tj
0.9978 0 Td
(three)Tj
2.2167 0 Td
(MVA-B)Tj
3.3789 0 Td
(vacci-)Tj
-34.7525 -1.2982 Td
(nations)Tj
3.118 0 Td
(given)Tj
2.3358 0 Td
(intramuscularly)Tj
6.4176 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.0296 0 Td
(Cryopreserved)Tj
5.9754 0 Td
(peripheral)Tj
4.2292 0 Td
(blood)Tj
2.4718 0 Td
(mononuclear)Tj
5.4765 0 Td
(cells)Tj
1.8765 0 Td
(\(PBMC\),)Tj
-33.9304 -1.3039 Td
(plasma)Tj
2.9763 0 Td
(and)Tj
1.7065 0 Td
(serum)Tj
2.6758 0 Td
(samples)Tj
3.3222 0 Td
(were)Tj
2.0863 0 Td
(stored)Tj
2.6532 0 Td
(for)Tj
1.3606 0 Td
(immunological)Tj
6.1795 0 Td
(and)Tj
1.7008 0 Td
(virological)Tj
4.3143 0 Td
(studies.)Tj
3.1408 0 Td
(Two)Tj
1.9956 0 Td
(patients)Tj
-34.1119 -1.2983 Td
(were)Tj
2.0862 0 Td
(excluded)Tj
3.7134 0 Td
(from)Tj
2.1713 0 Td
(the)Tj
1.44 0 Td
(present)Tj
3.1011 0 Td
(analysis;)Tj
3.4696 0 Td
(one)Tj
1.6724 0 Td
(because)Tj
3.2598 0 Td
(of)Tj
0.9922 0 Td
(consent)Tj
3.2711 0 Td
(withdrawal)Tj
4.6034 0 Td
(before)Tj
2.6873 0 Td
(vaccination)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 332.674 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Virological)Tj
4.7338 0 Td
(and)Tj
1.8568 0 Td
(immunolog)Tj
4.8047 0 Td
(ical)Tj
1.6866 0 Td
(outcome)Tj
3.9969 0 Td
(after)Tj
2.1898 0 Td
(HIV-1)Tj
2.7355 0 Td
(therapeutic)Tj
5.074 0 Td
(vaccine)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01849)Tj
4.089 0 Td
(29)Tj
0 g
2.0906 0 Td
(September)Tj
5.0386 0 Td
(27,)Tj
1.5874 0 Td
(2017)Tj
32.2798 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(15)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(the)Tj
1.3677 0 Td
(Ministerio)Tj
3.9047 0 Td
(de)Tj
1.1197 0 Td
(Econom)Tj
0 Tc
3.0119 0.0212 Td
()Tj
-0.025 Tc
0.248 -0.0212 Td
(a)Tj
0.6449 0 Td
(y)Tj
0.6378 0 Td
(Competitivida)Tj
5.0528 0 Td
(d)Tj
0.6945 0 Td
(del)Tj
-16.682 -1.3748 Td
(Gobierno)Tj
3.6212 0 Td
(de)Tj
1.1197 0 Td
(Espa)Tj
/F11 1 Tf
[( x)]TJ
/F10 1 Tf
(a)Tj
2.8489 0 Td
(and)Tj
1.5874 0 Td
(by)Tj
1.1197 0 Td
(2014)Tj
2.1118 0 Td
(SGR)Tj
1.9205 0 Td
(464)Tj
1.637 0 Td
(from)Tj
-15.9662 -1.3749 Td
(the)Tj
1.3677 0 Td
(Departament)Tj
5.0173 0 Td
(d'Econo)Tj
2.9764 0 Td
(mia)Tj
1.5875 0 Td
(i)Tj
0.4181 0 Td
(Coneixeme)Tj
4.1032 0 Td
(nt)Tj
0.9496 0 Td
(de)Tj
1.1126 0 Td
(la)Tj
-17.5324 -1.3748 Td
(Generalita)Tj
3.6921 0 Td
(t)Tj
0.4819 0 Td
(de)Tj
1.1126 0 Td
(Catalunya.)Tj
4.0465 0 Td
(The)Tj
1.5945 0 Td
(funders)Tj
3.0402 0 Td
(had)Tj
1.5945 0 Td
(no)Tj
1.1622 0 Td
(role)Tj
-16.7245 -1.3748 Td
(in)Tj
0.8858 0 Td
(study)Tj
2.2677 0 Td
(design,)Tj
2.8985 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7347 0 Td
(and)Tj
1.5945 0 Td
(analysis)Tj
2.9622 0 Td
(,)Tj
-16.1363 -1.3748 Td
(decision)Tj
3.2882 0 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1465 0 Td
(or)Tj
0.9992 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
-13.7764 -1.3748 Td
(manuscript.)Tj
/F9 1 Tf
0 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(I)Tj
0.4748 0 Td
(have)Tj
1.956 0 Td
(read)Tj
1.8425 0 Td
(the)Tj
1.3677 0 Td
(journal's)Tj
-13.8331 -1.3748 Td
(policy)Tj
2.3952 0 Td
(and)Tj
1.5875 0 Td
(the)Tj
1.3748 0 Td
(authors)Tj
3.0402 0 Td
(of)Tj
0.9496 0 Td
(this)Tj
1.5661 0 Td
(manuscript)Tj
4.415 0 Td
(have)Tj
1.9559 0 Td
(the)Tj
-17.2843 -1.3748 Td
(following)Tj
3.5858 0 Td
(competing)Tj
4.1599 0 Td
(interests:)Tj
3.6142 0 Td
(BM)Tj
1.5024 0 Td
(and)Tj
1.5874 0 Td
(CB)Tj
1.2685 0 Td
(are)Tj
-15.7182 -1.3749 Td
(inventors)Tj
3.6638 0 Td
(of)Tj
0.9425 0 Td
(an)Tj
1.1197 0 Td
(alternativ)Tj
3.3591 0 Td
(e)Tj
0.6448 0 Td
(HIV)Tj
1.5875 0 Td
(immunogen)Tj
4.7055 0 Td
(and)Tj
-16.0229 -1.3748 Td
(have)Tj
1.9559 0 Td
(financial)Tj
3.2669 0 Td
(interests)Tj
3.3945 0 Td
(in)Tj
0.8859 0 Td
(AELIX)Tj
2.4732 0 Td
(Therapeuti)Tj
ET
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
BT
15.8883 68.2162 Td
(cs.)Tj
ET
Q
endstream
endobj
55 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 59 0 R/Contents 60 0 R/TrimBox[0 0 612 792]>>
endobj
56 0 obj
<>
endobj
61 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
1 beginbfchar
<010D><03B3>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
62 0 obj
<>/FontDescriptor 63 0 R/DW 250/W[269[465]]>>
endobj
63 0 obj
<>
endobj
64 0 obj
<>stream
cvt f6 fpgm2Msf bglyfW headtr 6hhea1 $hmtx&O